Ibrahim M. Ibrahim

According to our database, Ibrahim M. Ibrahim authored at least 10 papers between 2021 and 2023.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of five.

2023

New thiazolidine-2,4-diones as effective anti-proliferative and anti-VEGFR-2 agents: Design, synthesis, in vitro, docking, MD simulations, DFT, ADMET, and toxicity studies.

Hazem Elkady, Abdelrahman A. Abuelkhir, Mahmoud Rashed, Mohammed S. Taghour, Mohammed A. Dahab, Hazem A. Mahdy, Alaa Elwan, Hanan A. Al-ghulikah, Eslam B. Elkaeed, Ibrahim M. Ibrahim, Dalal Z. Husein, Ahmed M. Metwaly, Ibrahim H. Eissa

Comput. Biol. Chem., December, 2023

Design, semi-synthesis, anti-cancer assessment, docking, MD simulation, and DFT studies of novel theobromine-based derivatives as VEGFR-2 inhibitors and apoptosis inducers.

Ibrahim H. Eissa, Reda G. Yousef, Hazem Elkady, Eslam B. Elkaeed, Aisha A. Alsfouk, Dalal Z. Husein, Ibrahim M. Ibrahim, Mostafa. A. Elhendawy, Murrell Godfrey, Ahmed M. Metwaly

Comput. Biol. Chem., December, 2023

<i>In vitro</i> and <i>in silico</i> evaluation of new thieno[2,3-<i>d</i>]pyrimidines as anti-cancer agents and apoptosis inducers targeting VEGFR-2.

Souad A. El-Metwally, Abdelrahman A. Abuelkhir, Hazem Elkady, Mohammed S. Taghour, Ibrahim M. Ibrahim, Dalal Z. Husein, Aisha A. Alsfouk, Ahlam Sultan, Ahmed Ismail, Samy Y. Elkhawaga, Eslam B. Elkaeed, Ahmed M. Metwaly, Ibrahim H. Eissa

Comput. Biol. Chem., October, 2023

Simulation of gold nanoparticle movement through normal and cancer cell membranes.

Abdo A. Elfiky, Ibrahim M. Ibrahim, Ahmed M. Elghareib, Yousef S. Bashandy, Ahmed Samir, Mayar M. Hamdy, Rana T. Kamal, Fatma G. Amin, Yomna Elkaramany, Anan M. Rashad, Youssef S. Abdelaziz, Mohamed M. Fathey

Comput. Biol. Medicine, September, 2023

Sizing of Microgrid System Including Multi-Functional Battery Storage and Considering Uncertainties.

Ibrahim M. Ibrahim, Almoataz Y. Abdelaziz, Hassan Haes Alhelou, Walid A. Omran

IEEE Access, 2023

2022

Interference of Chaga mushroom terpenoids with the attachment of SARS-CoV-2; <i>in silico</i> perspective.

Wael M. Elshemey, Abdo A. Elfiky, Ibrahim M. Ibrahim, Alaa M. Elgohary

Comput. Biol. Medicine, 2022

Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (M^pro) inhibitors to unveil a hope against COVID-19.

Sevki Adem, Volkan Eyupoglu, Ibrahim M. Ibrahim, Iqra Sarfraz, Azhar Rasul, Muhammad Ali, Abdo A. Elfiky

Comput. Biol. Medicine, 2022

2021

Dual targeting of cytokine storm and viral replication in COVID-19 by plant-derived steroidal pregnanes: An <i>in silico</i> perspective.

Gideon A. Gyebi, Oludare M. Ogunyemi, Ibrahim M. Ibrahim, Saheed O. Afolabi, Joseph O. Adebayo

Comput. Biol. Medicine, 2021

Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from <i>Vernonia amygdalina</i> and <i>Occinum gratissimum</i>.

Gideon A. Gyebi, Abdo A. Elfiky, Oludare M. Ogunyemi, Ibrahim M. Ibrahim, Adegbenro P. Adegunloye, Joseph O. Adebayo, Charles O. Olaiya, Joshua O. Ocheje, Modupe M. Fabusiwa

Comput. Biol. Medicine, 2021

Amyloid β fibrils disruption by kolaviron: Molecular docking and extended molecular dynamics simulation studies.

Kayode Ezekiel Adewole, Gideon A. Gyebi, Ibrahim M. Ibrahim

Comput. Biol. Chem., 2021